Comment on

• Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

  Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M. Berger T, et al. N Engl J Med. 2003 Jul 10;349(2):139-45. doi: 10.1056/NEJMoa022328. N Engl J Med. 2003. PMID: 12853586